Jama, Kimhar S.

HRN: 22-28-19  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/09/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/09/2022
12/16/2022
IV
500mg
Q8
CAP MR, Setic Shock, Intraabdominal Infection
Waiting Final Action 

Indication:  Empiric    Type of Infection:  PneumoniaBloodstreamIntra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: